Monday 1-Tuesday 2 December 2025, 8:30-17:00 GMT
Conway Hall, London and online
Course Director: Dr Charalampia Papadopoulou, Consultant Paediatric Rheumatologist, Great Ormond Street Hospital; Honorary Associate Professor, UCL Great Ormond Street Institute of Child Health; Chair, PReS Juvenile Dermatomyositis Working Party
Juvenile Idiopathic Inflammatory Myopathies (JIIM) are rare autoimmune diseases requiring highly specialised, multidisciplinary care. This two-day international course will provide cutting-edge updates on pathophysiology, diagnosis, and management of JIIM, with particular focus on interferon dysregulation and emerging targeted therapies. The programme integrates expert lectures, hands-on workshops (including muscle scoring and nailfold capillaroscopy), patient perspectives, and multidisciplinary input. Building on the success of the inaugural Lisbon course, the London 2025 meeting will foster collaboration, mentoring, and harmonisation of care and research across Europe and beyond.
This course is endorsed by PReS and sponsored by Novartis Pharmaceuticals UK Limited, Cabaletta Bio and Myositis UK. Further sponsors to be announced.
Our sponsors have provided financial sponsorship towards this independent programme and have had no involvement in its creation or organisation.
Learning objectives:
- Review classification, diagnosis, and management of JIIM in children.
- Explore advances in disease mechanisms and novel therapeutic strategies.
- Gain practical training in clinical scoring tools and nailfold capillaroscopy.
- Understand multidisciplinary approaches including physiotherapy, psychology, dermatology, and respiratory care.
- Integrate patient and family perspectives into clinical practice.
- Build international collaborations and mentorship opportunities for trainees and young investigators.
Who should attend?
- Paediatric and rheumatology resident doctors (trainees) and consultants
- Allied health professionals (physiotherapists, occupational therapists), specialist nurses, psychologists
- Clinical scientists and researchers
- Respiratory physicians, dermatologists, neurologists
Programme:
The programme is attached.
Opportunity to participate in case vignette presentations:
Trainees/early-career investigators are invited to participate in case vignette presentations. Please send expressions of interest, including a short description of your case, to the Course Director Dr Charalampia Papadopoulou (Charalampia.Papadopoulou@gosh.nhs.uk) by Friday 31 October. Those invited to present will be notified in early November, with further information provided at this stage. Please note that presenters have to book a face-to-face ticket to take part; virtual presentations are not possible.
Pricing:
- Face-to-Face tickets (includes lunch and refreshments) - £240
- Virtual tickets - £175 Please note that virtual delegates are unable to participate in the two practical workshops on Tuesday 2 December.
Please email events.gla@gosh.nhs.uk if you need to pay via invoice through your Trust/organisation. If paying by invoice, a PO from your Trust/Organisation is required 14 working days before the start of the event to confirm your place.
GOSH staff wishing to attend face-to-face can either a) pay via debit/credit card (if they plan to self-fund their ticket) or b) apply through the Study Leave Fund or departmental funds (where applicable). Those applying via route b should follow the process on the study leave application form. Please email events.gla@gosh.nhs.uk if you require assistance.
Registration:
Please note that face-to-face registration will close on Monday 24 November 2025, 9:00 GMT.
Virtual tickets will remain on sale until Monday 1 December 2025, 8:00 GMT.
CPD:
RCPCH CPD approval is being applied for. Where approved, the basic unit of CPD activity is 1 hour of learning equals 1 CPD credit.
Recording:
Please note that this event will be recorded (subject to speakers’ consent), with the recording shared with delegates within three weeks of the course taking place. The recording will be available for a short period (at least three months).